ONCOEXTRA Trademark

Trademark Overview


On Monday, January 9, 2023, a trademark application was filed for ONCOEXTRA with the United States Patent and Trademark Office. The USPTO has given the ONCOEXTRA trademark a serial number of 97746100. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Thursday, January 18, 2024. This trademark is owned by Genomic Health, Inc.. The ONCOEXTRA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic and prognostic purposes and therapy selection in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionals, namely, oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer
oncoextra

General Information


Serial Number97746100
Word MarkONCOEXTRA
Filing DateMonday, January 9, 2023
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateThursday, January 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements


Description of MarkThe mark consists of the word "ONCOEXTRA" in stylized font.
Pseudo MarkON CO EXTRA
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical testing for diagnostic and prognostic purposes and therapy selection in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionals, namely, oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 31, 2023
Primary Code044
First Use Anywhere DateMonday, February 6, 2023
First Use In Commerce DateMonday, February 6, 2023

Trademark Owner History


Party NameGenomic Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Party NameGenomic Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events


Event DateEvent Description
Tuesday, January 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 18, 2024NON-FINAL ACTION E-MAILED
Thursday, January 18, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, January 4, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 12, 2023USE AMENDMENT FILED
Wednesday, January 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 12, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 8, 2023ASSIGNED TO EXAMINER
Tuesday, January 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 12, 2023NEW APPLICATION ENTERED